The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Open accessAbstract
BACKGROUND: Lung cancer risks at which individuals should be screened with computed tomography (CT) for lung cancer are undecided. This study's objectives are to identify a risk threshold for selecting individuals for screening, to compare its efficiency with the U.S. Preventive Services Task Force (USPSTF) criteria for identifying screenees, and to determine whether never-smokers should be screened. Lung cancer risks are compared between smokers aged 55-64 and ≥ 65-80 y. METHODS AND FINDINGS: Applying the PLCO(m2012) model, a model based on 6-y lung cancer incidence, we identified the risk threshold above which National Lung Screening Trial (NLST, n = 53,452) CT arm lung cancer mortality rates were consistently lower than rates in the chest X-ray (CXR) arm. We evaluated the USPSTF and PLCO(m2012) risk criteria in intervention arm (CXR) smokers (n = 37,327) of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). The numbers of smokers selected for screening, and the sensitivities, specificities, and positive predictive values (PPVs) for identifying lung cancers were assessed. A modified model (PLCOall2014) evaluated risks in never-smokers. At PLCO(m2012) risk ≥ 0.0151, the 65th percentile of risk, the NLST CT arm mortality rates are consistently below the CXR arm's rates. The number needed to screen to prevent one lung cancer death in the 65th to 100th percentile risk group is 255 (95% CI 143 to 1,184), and in the 30th to <65th percentile risk group is 963 (95% CI 291 to -754); the number needed to screen could not be estimated in the <30th percentile risk group because of absence of lung cancer deaths. When applied to PLCO intervention arm smokers, compared to the USPSTF criteria, the PLCO(m2012) risk ≥ 0.0151 threshold selected 8.8% fewer individuals for screening (p<0.001) but identified 12.4% more lung cancers (sensitivity 80.1% [95% CI 76.8%-83.0%] versus 71.2% [95% CI 67.6%-74.6%], p<0.001), had fewer false-positives (specificity 66.2% [95% CI 65.7%-66.7%] versus 62.7% [95% CI 62.2%-63.1%], p<0.001), and had higher PPV (4.2% [95% CI 3.9%-4.6%] versus 3.4% [95% CI 3.1%-3.7%], p<0.001). In total, 26% of individuals selected for screening based on USPSTF criteria had risks below the threshold PLCO(m2012) risk ≥ 0.0151. Of PLCO former smokers with quit time >15 y, 8.5% had PLCO(m2012) risk ≥ 0.0151. None of 65,711 PLCO never-smokers had PLCO(m2012) risk ≥ 0.0151. Risks and lung cancers were significantly greater in PLCO smokers aged ≥ 65-80 y than in those aged 55-64 y. This study omitted cost-effectiveness analysis. CONCLUSIONS: The USPSTF criteria for CT screening include some low-risk individuals and exclude some high-risk individuals. Use of the PLCO(m2012) risk ≥ 0.0151 criterion can improve screening efficiency. Currently, never-smokers should not be screened. Smokers aged ≥ 65-80 y are a high-risk group who may benefit from screening. Please see later in the article for the Editors' Summary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Density Estimation for Statistics and Data Analysis
Silverman, B. W. (2018) · Routledge eBooks · doi:10.1201/9781315140919 · Cited by 15,796
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064 · cited 2×
“The NNS to prevent one lung cancer death in the 65th to 100th percentile risk group is 255 (95% CI 143 to 1,184), which is statistically significant, and is a 25% improvement over the NNS of 320 reported for the NLST as a whole [1].”
BackgroundHarrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Interval Estimation for a Binomial Proportion
Brown, L. D., Cai, T. T., & DasGupta, A. (2001) · Statistical Science · doi:10.1214/ss/1009213286 · Cited by 3,538
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
A wilcoxon‐type test for trend
Cuzick, J. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040112 · Cited by 1,900
RE: “ESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES”
Halperin, M. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112409 · Cited by 1,542
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
McWilliams, A., Tammemagi, M. C., Mayo, J. R., Roberts, H., Liu, G., Soghrati, K., Yasufuku, K., Martel, S., Laberge, F., Gingras, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214726 · Cited by 1,414
Self-citationESTIMABILITY AND ESTIMATION IN CASE-REFERENT STUDIES
MIETTINEN, O. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112220 · Cited by 1,321
The National Lung Screening Trial: Overview and Study Design
National Lung Screening Trial Research Team (2011) · Radiology · doi:10.1148/radiol.10091808 · Cited by 1,274
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
Bach, P. B., Mirkin, J. N., Oliver, T. K., Azzoli, C. G., Berry, D. A., Brawley, O. W., Byers, T., Colditz, G. A., Gould, M. K., Jett, J. R., et al. (2012) · JAMA · doi:10.1001/jama.2012.5521 · Cited by 1,244
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
Prorok, P. C., Andriole, G. L., Bresalier, R. S., Buys, S. S., Chia, D., David Crawford, E., Fogel, R., Gelmann, E. P., Gilbert, F., Hasson, M. A., et al. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00098-2 · Cited by 1,037
Selection Criteria for Lung-Cancer Screening
Tammemägi, M. C., Katki, H. A., Hocking, W. G., Church, T. R., Caporaso, N., Kvale, P. A., Chaturvedi, A. K., Silvestri, G. A., Riley, T. L., Commins, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211776 · Cited by 1,029
Self-citationEpidemiology: Study Design and Data Analysis
(2006) · Technometrics · doi:10.1198/tech.2006.s407 · Cited by 788
American Cancer Society lung cancer screening guidelines
Wender, R., Fontham, E. T. H., Barrera, E., Colditz, G. A., Church, T. R., Ettinger, D. S., Etzioni, R., Flowers, C. R., Scott Gazelle, G., Kelsey, D. K., et al. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21172 · Cited by 723
Self-citationOken, M. M., Hocking, W. G., Kvale, P. A., Andriole, G. L., Buys, S. S., Church, T. R., Crawford, E. D., Fouad, M. N., Isaacs, C., Reding, D. J., et al. (2011) · JAMA · doi:10.1001/jama.2011.1591 · Cited by 655
Self-citationJaklitsch, M. T., Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S., MacMahon, H., Mulshine, J. L., Munden, R. F., Salgia, R., et al. (2012) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.05.060 · Cited by 608
Patz, E. F., Goodman, P. C., & Bepler, G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432208 · Cited by 599
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Kovalchik, S. A., Tammemagi, M., Berg, C. D., Caporaso, N. E., Riley, T. L., Korch, M., Silvestri, G. A., Chaturvedi, A. K., & Katki, H. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301851 · Cited by 575
Self-citationLung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors
Samet, J. M., Avila-Tang, E., Boffetta, P., Hannan, L. M., Olivo-Marston, S., Thun, M. J., & Rudin, C. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0376 · Cited by 566
Two Further Applications of a Model for Binary Regression
Cox, D. R. (1958) · Biometrika · doi:10.2307/2333203 · Cited by 557
Two further applications of a model for binary regression
COX, D. R. (1958) · Biometrika · doi:10.1093/biomet/45.3-4.562 · Cited by 556
The LLP risk model: an individual risk prediction model for lung cancer
Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., & Field, J. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604158 · Cited by 490
Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies
Thun, M. J., Hannan, L. M., Adams-Campbell, L. L., Boffetta, P., Buring, J. E., Feskanich, D., Flanders, W. D., Jee, S. H., Katanoda, K., Kolonel, L. N., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050185 · Cited by 482
de Koning, H. J., Meza, R., Plevritis, S. K., ten Haaf, K., Munshi, V. N., Jeon, J., Erdogan, S. A., Kong, C. Y., Han, S. S., van Rosmalen, J., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2316 · Cited by 466
Self-citationMulshine, J. L., & Sullivan, D. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042630 · Cited by 419
Baseline Characteristics of Participants in the Randomized National Lung Screening Trial
The National Lung Screening Trial Research Team Writing committee:, Aberle, D. R., Adams, A. M., Berg, C. D., Clapp, J. D., Clingan, K. L., Gareen, I. F., Lynch, D. A., Marcus, P. M., & Pinsky, P. F. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq434 · Cited by 322
Self-citationEstimation and Comparison of Receiver Operating Characteristic Curves
Pepe, M. S., Longton, G., & Janes, H. (2009) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0900900101 · Cited by 306
Wood, D. E., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D., Kazerooni, E., Klippenstein, D., Lackner, R. P., Leard, L., Leung, A. N. C., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0022 · Cited by 227
Calculating Confidence Intervals for the Number Needed to Treat
Bender, R. (2001) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00134-3 · Cited by 214
Sample Size for Testing Differences in Proportions for the Paired-Sample Design
Connor, R. J. (1987) · Biometrics · doi:10.2307/2531961 · Cited by 187
Raji, O. Y., Duffy, S. W., Agbaje, O. F., Baker, S. G., Christiani, D. C., Cassidy, A., & Field, J. K. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-4-201208210-00004 · Cited by 181
Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts
Silvestri, G. A., Nietert, P. J., Zoller, J., Carter, C., & Bradford, D. (2007) · Thorax · doi:10.1136/thx.2005.056036 · Cited by 174
Self-citationLung cancer incidence trends among men and women--United States, 2005-2009.
Henley, S. J., Richards, T. B., Underwood, J. M., Eheman, C. R., Plescia, M., & McAfee, T. A. (2014) · PubMed Central · Cited by 159
Standards for Libraries in Higher Education
Iannuzzi, P. A., Abbott, T., Brown, J. M., Gibbons, S., King, L., McCaslin, S., Reichel, M., Ruelle, J., Stillwell, L., Petrowski, M. J., et al. (2011) · Digital Scholarship - UNLV (University of Nevada Reno) · Cited by 147
Oken, M. M., Marcus, P. M., Hu, P., Beck, T., Hocking, W. G., Kvale, P. A., Cordes, J. E., Riley, T. L., Winslow, S. D., Peace, S., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji430 · Cited by 127
Self-citationGroeneveld, I. F., Proper, K. I., van der Beek, A. J., Hildebrandt, V. H., & van Mechelen, W. (2009) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/1479-5868-6-80 · Cited by 111
Couraud, S., Cortot, A. B., Greillier, L., Gounant, V., Mennecier, B., Girard, N., Besse, B., Brouchet, L., Castelnau, O., Frappé, P., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds476 · Cited by 107
Bach, P. B., & Gould, M. K. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-8-201210160-00524 · Cited by 87
Screening High-Risk Populations for Lung Cancer: Guideline Recommendations
Roberts, H. C., Walker‐Dilks, C., Sivjee, K., Ung, Y., Yasufuku, K., Hey, A., & Lewis, N. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829fd3d5 · Cited by 78
Mobile learning for the twenty‐first century librarian
Hahn, J. (2008) · Reference Services Review · doi:10.1108/00907320810895369 · Cited by 67
U.S. Preventive Services Task Force
Mickalide, A. D. (1986) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36086-2 · Cited by 67
Factors determining early adherence to a lung cancer screening protocol
Montes, U., Seijo, L. M., Campo, A., Alcaide, A. B., Bastarrika, G., & Zulueta, J. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00143206 · Cited by 58
Kundisch, D., Magenheim, J., Beutner, M., Herrmann, P., Reinhardt, W., & Zokye, A. (2013) · Informatik-Spektrum · doi:10.1007/s00287-013-0713-0 · Cited by 37
Cited by
Cancer Progress and Priorities: Lung Cancer
Schabath, M. B., & Cote, M. L. (2019) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0221 · Cited by 1,160
Progress and prospects of early detection in lung cancer
Blandin Knight, S., Crosbie, P. A., Balata, H., Chudziak, J., Hussell, T., & Dive, C. (2017) · Open Biology · doi:10.1098/rsob.170070 · Cited by 935
Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology
Wood, D. E., Kazerooni, E. A., Baum, S. L., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D., Kumar, R., Lackner, R. P., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0020 · Cited by 611
Mazzone, P. J., Silvestri, G. A., Patel, S., Kanne, J. P., Kinsinger, L. S., Wiener, R. S., Soo Hoo, G., & Detterbeck, F. C. (2018) · Chest · doi:10.1016/j.chest.2018.01.016 · Cited by 348
Self-citationDevelopment and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening
Katki, H. A., Kovalchik, S. A., Berg, C. D., Cheung, L. C., & Chaturvedi, A. K. (2016) · JAMA · doi:10.1001/jama.2016.6255 · Cited by 338
Self-citation
Metadata
- Authors
- Tammemägi, M. C., Church, T. R., Hocking, W. G., Silvestri, G. A., Kvale, P. A., Riley, T. L., Commins, J., & Berg, C. D.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-12-02
- Volume
- 11
- Issue
- 12
- Pages
- e1001764
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2029944316
- Cited by
- 358
- References
- 44
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.